Chemomab Therapeutics CMMB
NASDAQ CMMB
$2.69 -0.06 (-2.18%)
At close: Sep 9, 2026 · 4:00 PM EDT

Chemomab Therapeutics (CMMB) Pension (2018)

Chemomab Therapeutics' (CMMB) quarterly Pension came in at $210000.0 in Q4 2018.

Analysis

Chemomab Therapeutics (CMMB) Pension (2018) Analysis & Trends

Chemomab Therapeutics (CMMB) has reported Pension for 1 consecutive years, with $210000.0 the latest figure, recorded in Q4 2018.

  • For the quarter ending Q4 2018, Pension changed N/A year-over-year to $210000.0; the trailing twelve-month figure through Dec 2018 stood at $210000.0 (changed N/A YoY), and the FY2018 full-year result was $210000.0, changed N/A from the prior year.
  • Pension was little changed at $210000.0 in Q4 2018 per CMMB's latest filing.
  • Across five years, Pension topped out at $210000.0 in Q4 2018 and bottomed at $210000.0 in Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Chemomab Therapeutics 19.49 Mn 19.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 210,000.00